Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013

被引:278
作者
Compston, J. [10 ]
Bowring, C.
Cooper, A. [3 ]
Cooper, C. [6 ,7 ,8 ]
Davies, C.
Francis, R. [1 ]
Kanis, J. A. [9 ]
Marsh, D. [11 ]
McCloskey, E. V. [4 ,5 ]
Reid, D. M. [2 ]
Selby, P. [12 ]
机构
[1] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Aberdeen, Sch Med & Dent, Aberdeen AB9 1FX, Scotland
[3] Bridge Med Ctr, Crawley, W Sussex, England
[4] Univ Sheffield, Acad Unit Bone Metab, Sheffield S10 2TN, S Yorkshire, England
[5] Univ Sheffield, Mellanby Ctr Bone Res, Sheffield S10 2TN, S Yorkshire, England
[6] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton SO9 5NH, Hants, England
[7] Univ Hosp, NIHR Nutr Biomed Res Ctr, Southampton, Hants, England
[8] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford OX1 2JD, England
[9] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sheffield S10 2TN, S Yorkshire, England
[10] Univ Cambridge, Sch Clin Med, Cambridge CB2 1TN, England
[11] Univ Coll London, Royal Natl Orthopaed Hosp, Dept Clin Orthopaed, Stanmore, Middx, England
[12] Manchester Royal Infirm, Dept Med, Manchester, Lancs, England
关键词
Osteoporosis; Fracture; FRAX; Guideline; VITAMIN-D; RISK; SUPPLEMENTS; PREDICTION; EXTENSION; TRIAL;
D O I
10.1016/j.maturitas.2013.05.013
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
030301 [社会学]; 100201 [内科学];
摘要
Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 9 条
[1]
Do calcium plus vitamin D supplements increase cardiovascular risk? [J].
Abrahamsen, Bo ;
Sahota, Opinder .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[2]
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].
Black, Dennis M. ;
Reid, Ian R. ;
Boonen, Steven ;
Bucci-Rechtweg, Christina ;
Cauley, Jane A. ;
Cosman, Felicia ;
Cummings, Steven R. ;
Hue, Trisha F. ;
Lippuner, Kurt ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Martinez, Ruvie Lou Maria ;
Tan, Monique ;
Ruzycky, Mary Ellen ;
Su, Guoqin ;
Eastell, Richard .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254
[3]
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[4]
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis [J].
Bolland, Mark J. ;
Grey, Andrew ;
Avenell, Alison ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[5]
Does osteoporosis therapy invalidate FRAX for fracture prediction? [J].
Leslie, William D. ;
Lix, Lisa M. ;
Johansson, Helena ;
Oden, Anders ;
McCloskey, Eugene ;
Kanis, John A. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (06) :1243-1251
[6]
Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg) [J].
Li, Kuanrong ;
Kaaks, Rudolf ;
Linseisen, Jakob ;
Rohrmann, Sabine .
HEART, 2012, 98 (12) :920-925
[7]
National Osteoporosis Society, 2013, VIT D BON HLTH PRACT
[8]
Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: Prediction of bone mass changes during treatment [J].
Ravn, P ;
Christensen, JO ;
Baumann, C ;
Clemmesen, B .
BONE, 1998, 22 (05) :559-564
[9]
Fracture risk remains reduced one year after discontinuation of risedronate [J].
Watts, N. B. ;
Chines, A. ;
Olszynski, W. P. ;
McKeever, C. D. ;
McClung, M. R. ;
Zhou, X. ;
Grauer, A. .
OSTEOPOROSIS INTERNATIONAL, 2008, 19 (03) :365-372